Ching-Hua Lin Selected Research

Fluoxetine (Prozac)

12/2020	Electroconvulsive Therapy Versus Fluoxetine in Suicidal Resolution for Patients With Major Depressive Disorder.
1/2019	Do baseline WAIS-III subtests predict treatment outcomes for depressed inpatients receiving fluoxetine?
1/2019	Early improvement in HAMD-17 and HAMD-7 scores predict response and remission in depressed patients treated with fluoxetine or electroconvulsive therapy.
1/2019	Early improvement in HAMD-17 and HAMD-6 scores predicts ultimate response and remission for depressed patients treated with fluoxetine or ECT.
1/2018	ECT Has Greater Efficacy Than Fluoxetine in Alleviating the Burden of Illness for Patients with Major Depressive Disorder: A Taiwanese Pooled Analysis.
1/2017	Factors related to the improvement in quality of life for depressed inpatients treated with fluoxetine.
12/2015	Pain Affects Clinical Patterns and Treatment Outcomes for Patients With Major Depressive Disorder Taking Fluoxetine.
8/2015	The relationship between symptom relief and functional improvement during acute fluoxetine treatment for patients with major depressive disorder.
12/2014	Comparison of physician-rating and self-rating scales for patients with major depressive disorder.
6/2014	Both body weight and BMI predicts improvement in symptom and functioning for patients with major depressive disorder.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ching-Hua Lin Research Topics

Disease

28	Schizophrenia (Dementia Praecox) 09/2022 - 10/2003
19	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 06/2007
4	Weight Gain 01/2018 - 11/2002
4	Pain (Aches) 12/2015 - 11/2011
4	Alcoholism (Alcohol Abuse) 07/2014 - 06/2007
3	Treatment-Resistant Schizophrenia 10/2020 - 05/2008
3	Body Weight (Weight, Body) 06/2014 - 09/2002
3	Body Weight Changes 01/2004 - 09/2002
2	Treatment-Resistant Depressive Disorder 01/2022 - 01/2013
2	Bipolar Disorder (Manic Depressive Psychosis) 01/2021 - 10/2019
2	Mania (Manias) 01/2021 - 01/2021
2	Personality Disorders (Personality Disorder) 01/2008 - 06/2007
1	Diabetes Mellitus 09/2022
1	Psychotic Disorders (Schizoaffective Disorder) 03/2022
1	Edema (Dropsy) 01/2021
1	Constipation 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019
1	Hemiplegia (Spastic Hemiplegia) 01/2017
1	Paraplegia (Spastic Paraplegia) 01/2017
1	Substance-Related Disorders (Drug Abuse) 11/2014
1	Hypertension (High Blood Pressure) 08/2011
1	Hyperglycemia 08/2011
1	Mental Disorders (Mental Disorder) 04/2011
1	Alopecia (Baldness) 10/2010
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2010
1	Tobacco Use Disorder (Nicotine Dependence) 01/2008
1	Anxiety Disorders (Anxiety Disorder) 01/2008
1	Hepatitis 12/2005
1	Coma (Comas) 12/2005
1	Alzheimer Disease (Alzheimer's Disease) 01/2004
1	Parkinson Disease (Parkinson's Disease) 12/2003
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2003

Drug/Important Bio-Agent (IBA)

22	Antipsychotic Agents (Antipsychotics)IBA 09/2022 - 09/2002
15	Fluoxetine (Prozac)FDA LinkGeneric 12/2020 - 01/2008
9	Clozapine (Clozaril)FDA LinkGeneric 06/2022 - 09/2002
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2013 - 10/2003
2	LaxativesIBA 09/2022 - 01/2021
2	Risperidone (Risperdal Consta)FDA LinkGeneric 03/2022 - 10/2010
2	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2019 - 12/2013
2	Messenger RNA (mRNA)IBA 01/2019 - 01/2016
2	D-Amino-Acid Oxidase (D-Amino Acid Dehydrogenase)IBA 01/2018 - 12/2013
2	Olanzapine (Zyprexa)FDA Link 01/2018 - 01/2017
2	Sodium Benzoate FDA Link 01/2018 - 12/2013
2	Pharmaceutical PreparationsIBA 01/2016 - 12/2013
1	Paliperidone Palmitate FDA Link 06/2022
1	agomelatine (S20098)IBA 01/2022
1	Lurasidone Hydrochloride FDA Link 01/2021
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2021
1	Folic Acid (Vitamin M)FDA LinkGeneric 10/2019
1	MagnesiumIBA 01/2019
1	A 7 (A-7)IBA 01/2018
1	Trifluoperazine (Stelazine)FDA LinkGeneric 01/2017
1	LipidsIBA 01/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2017
1	Short-Acting InsulinIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	AntiportersIBA 01/2016
1	Glutamic Acid (Glutamate)FDA Link 01/2016
1	Cystine (L-Cystine)IBA 01/2016
1	Methamphetamine (Desoxyn)FDA LinkGeneric 11/2014
1	Diazepam (Valium)FDA LinkGeneric 11/2014
1	chemotactic factor inactivatorIBA 09/2014
1	Benzoates (Benzoate)IBA 12/2013
1	Sulpiride (neogama)IBA 09/2013
1	Amisulpride (Solian)IBA 09/2013
1	Antidepressive Agents (Antidepressants)IBA 11/2011
1	Triglycerides (Triacylglycerol)IBA 08/2011
1	BenzodiazepinesIBA 04/2011
1	Haloperidol (Haldol)FDA LinkGeneric 10/2010
1	Mirtazapine (Rexer)FDA LinkGeneric 10/2010
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 05/2010
1	Serine (L-Serine)FDA Link 05/2010
1	Sarcosine (Methylglycine)IBA 05/2010
1	N-Methylaspartate (NMDA)IBA 05/2010
1	A-factor (Streptomyces)IBA 05/2008
1	DNA (Deoxyribonucleic Acid)IBA 05/2008
1	Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric 01/2008
1	zotepineIBA 10/2007
1	Chloroform (Trichloromethane)IBA 12/2005
1	G-protein beta3 subunitIBA 01/2004
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2004
1	Proteins (Proteins, Gene)FDA Link 12/2003
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2003
1	Immunologic Factors (Immunomodulators)IBA 12/2003
1	CytokinesIBA 12/2003
1	Histamine H1 Receptors (Histamine H1 Receptor)IBA 09/2002

Therapy/Procedure

11	Patient Readmission 03/2022 - 06/2006
4	Injections 01/2022 - 01/2019
3	Therapeutics 01/2018 - 12/2013
2	Polypharmacy 12/2019 - 01/2017
2	Length of Stay 11/2014 - 08/2010
1	Home Nursing (Nursing, Home) 06/2022
1	Transcranial Magnetic Stimulation 01/2021
1	Duration of Therapy 01/2018
1	Liver Transplantation 12/2005